TSH Biopharm (8432.TWO) Earnings Analysis
TSH Biopharm (8432.TWO) next reports earnings on 2026-07-30, consensus EPS 1.08 TWD. Trailing P/E 13.10.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 8432.TWO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 1.08 TWD |
| Revenue estimate | 0.32B |
8432.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | 0.62 TWD | n/a | n/a | n/a |
| 2025-06-30 | 0.68 TWD | n/a | n/a | n/a |
| 2025-03-31 | 0.79 TWD | n/a | n/a | n/a |
| 2024-12-31 | 0.2494 TWD | n/a | n/a | n/a |
| 2024-09-30 | 1.26 TWD | n/a | n/a | n/a |
8432.TWO valuation and analyst view
| Trailing P/E | 13.10 |
|---|---|
| Trailing EPS | 4.252 TWD |
| Price / book | 1.31 |
| Dividend yield | 5.19% |
| Market cap | 1.92B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is TSH Biopharm (8432.TWO)'s next earnings date?
TSH Biopharm is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.08 TWD and revenue estimate of 0.32B.
Did 8432.TWO beat earnings last quarter?
Consensus estimate data was not available for 8432.TWO's 2026-03-05 report.
What is 8432.TWO's current P/E ratio and EPS?
8432.TWO trades at a trailing P/E of 13.10 on trailing EPS of 4.251679774988281 TWD.
What do analysts rate 8432.TWO?
8432.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.